Compare Sun Pharma with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs J.B.CHEMICALS - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA J.B.CHEMICALS SUN PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 22.5 20.2 111.4% View Chart
P/BV x 2.6 2.8 94.5% View Chart
Dividend Yield % 0.6 0.4 143.7%  

Financials

 SUN PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    SUN PHARMA
Mar-19
J.B.CHEMICALS
Mar-18
SUN PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs679363 186.9%   
Low Rs375255 147.2%   
Sales per share (Unadj.) Rs121.1169.1 71.6%  
Earnings per share (Unadj.) Rs13.416.6 80.6%  
Cash flow per share (Unadj.) Rs20.723.4 88.3%  
Dividends per share (Unadj.) Rs2.752.00 137.5%  
Dividend yield (eoy) %0.50.6 80.6%  
Book value per share (Unadj.) Rs172.6172.5 100.1%  
Shares outstanding (eoy) m2,399.2683.57 2,871.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.41.8 238.1%   
Avg P/E ratio x39.418.6 211.6%  
P/CF ratio (eoy) x25.513.2 193.1%  
Price / Book Value ratio x3.11.8 170.5%  
Dividend payout %20.612.0 170.6%   
Avg Mkt Cap Rs m1,264,65025,827 4,896.6%   
No. of employees `00017.53.8 464.0%   
Total wages/salary Rs m59,6712,511 2,376.4%   
Avg. sales/employee Rs Th16,608.13,747.4 443.2%   
Avg. wages/employee Rs Th3,409.6665.7 512.2%   
Avg. net profit/employee Rs Th1,833.8367.8 498.6%   
INCOME DATA
Net Sales Rs m290,65914,135 2,056.3%  
Other income Rs m10,255366 2,803.4%   
Total revenues Rs m300,91414,501 2,075.1%   
Gross profit Rs m63,0762,178 2,895.6%  
Depreciation Rs m17,533570 3,077.5%   
Interest Rs m5,55335 15,909.7%   
Profit before tax Rs m50,2461,940 2,590.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-12,1440-   
Tax Rs m6,009552 1,088.0%   
Profit after tax Rs m32,0931,387 2,313.5%  
Gross profit margin %21.715.4 140.8%  
Effective tax rate %12.028.5 42.0%   
Net profit margin %11.09.8 112.5%  
BALANCE SHEET DATA
Current assets Rs m310,69210,470 2,967.4%   
Current liabilities Rs m173,3962,749 6,307.6%   
Net working cap to sales %47.254.6 86.5%  
Current ratio x1.83.8 47.0%  
Inventory Days Days9955 179.4%  
Debtors Days Days11278 143.7%  
Net fixed assets Rs m232,4775,811 4,000.5%   
Share capital Rs m2,399167 1,435.8%   
"Free" reserves Rs m411,69114,248 2,889.4%   
Net worth Rs m414,09114,416 2,872.5%   
Long term debt Rs m15,2260-   
Total assets Rs m646,93817,649 3,665.6%  
Interest coverage x10.056.6 17.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40.8 56.1%   
Return on assets %5.88.1 72.2%  
Return on equity %7.89.6 80.5%  
Return on capital %10.213.7 74.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m66,0256,164 1,071.2%   
Fx outflow Rs m38,6101,334 2,893.4%   
Net fx Rs m27,4154,829 567.7%   
CASH FLOW
From Operations Rs m21,9651,231 1,785.0%  
From Investments Rs m-6,813-208 3,273.7%  
From Financial Activity Rs m-27,305-595 4,587.6%  
Net Cashflow Rs m-8,442427 -1,976.5%  

Share Holding

Indian Promoters % 63.7 55.4 115.0%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 5.1 3.4 151.3%  
FIIs % 23.0 3.9 589.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.3 37.0 22.4%  
Shareholders   133,026 30,437 437.1%  
Pledged promoter(s) holding % 0.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  CIPLA  ALKEM LABORATORIES  

Compare SUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Scales 42,000 and Smallcaps Rebound: What Happens Next?(Podcast)

This week, the BSE Sensex crossed 42,000 level for the first time. While Nifty followed suit, hitting a record high of 12,377.

Related Views on News

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth?(The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Multibaggers of the Next Decade(The 5 Minute Wrapup)

Jan 6, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jan 17, 2020 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - ALEMBIC PHARMA COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS